Investigating genetic and environmental factors in cardiovascular and renal diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The STANISLAS Cohort is a long-term study involving families to explore how genetic and environmental factors contribute to cardiovascular aging and the onset of related diseases. This fifth visit will assess various health parameters, including cardiovascular and renal function, using data collected over decades. Participants will undergo comprehensive evaluations, including blood and urine samples, dietary assessments, and cardiovascular assessments to identify risk factors and potential biomarkers. The study aims to deepen our understanding of how these factors interact and influence health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* aged over 18
* Person who participated in the Stanislas Cohort
* Person affiliated to a social security scheme or beneficiary of such a scheme
* Person having received complete information on the organization of the research and having signed an informed consent

Exclusion Criteria:

* Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric treatment under Articles L. 3212-1 and L. 3213-1
* Person referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code:

  * Pregnant woman, parturient or nursing mother
  * Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
  * Person of full age unable to express consent

Where it's running

• CHRU de Nancy
  Vandœuvre-lès-Nancy, Lorraine, France Recruiting

Study contacts

• Principal investigator: Nicolas Girerd, MD, PhD — Centre d'Investigation Clinique 1433 module Plurithématique - CHRU Nancy

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Health dialogues to improve cardiovascular health in Skåne

  This study is testing a program that has health conversations with 40-year-olds in Skåne to see if it can help improve their heart health.

  Recruiting Region Skane · Malmö, Skåne County · NCT04912739

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.